Ardevora Asset Management LLP - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 253 filers reported holding REPLIGEN CORP in Q1 2019. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.

Quarter-by-quarter ownership
Ardevora Asset Management LLP ownership history of REPLIGEN CORP
ValueSharesWeighting
Q4 2021$65,596,000
-16.3%
247,683
-8.6%
0.70%
-29.6%
Q3 2021$78,340,000
+38.9%
271,083
-4.1%
0.99%
+39.7%
Q2 2021$56,409,000
+12.5%
282,583
+9.6%
0.71%
-4.7%
Q1 2021$50,145,000
-9.9%
257,933
-11.2%
0.75%
-13.2%
Q4 2020$55,632,000
+21.7%
290,310
-38.7%
0.86%
-29.1%
Q1 2020$45,705,000
-3.8%
473,433
-14.4%
1.21%
+4.3%
Q2 2019$47,520,000
+35.2%
552,877
-7.1%
1.16%
+26.6%
Q1 2019$35,151,000
+8.9%
594,977
-2.8%
0.92%
-5.1%
Q4 2018$32,281,000
+443.7%
612,077
+471.7%
0.97%
+486.1%
Q3 2018$5,937,000107,0570.16%
Other shareholders
REPLIGEN CORP shareholders Q1 2019
NameSharesValueWeighting ↓
12 West Capital Management LP 1,021,641$295,244,00013.47%
Ally Bridge Group (NY) LLC 70,000$20,229,0005.95%
Miura Global Management 85,000$24,564,0003.81%
Conestoga Capital Advisors, LLC 871,390$251,823,0003.48%
Ranger Investment Management 187,723$54,250,0002.90%
AWM Investment Company, Inc. 100,000$28,899,0002.84%
Brown Capital Management 1,017,477$294,041,0002.41%
Stephens Investment Management Group LLC 558,287$161,339,0002.19%
Yorktown Management & Research Co Inc 10,050$2,904,0002.18%
SV Health Investors, LLC 14,541$4,203,0002.06%
View complete list of REPLIGEN CORP shareholders